Michael Vander - Dec 29, 2022 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role: Chief Financial Officer
Signature: /s/ Michael Vander Hoek
Stock symbol: SHPH
Transactions as of: Dec 29, 2022
Transactions value $: -$3,600
Form type: 4
Date filed: 12/30/2022, 03:06 PM
Previous filing: Sep 7, 2022
Next filing: Mar 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SHPH	COMMON STOCK	Sale	-$3.6K	-2.24K	-36.8%	$1.61	3.85K	Dec 29, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,095 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
F2	Consists of 3,852 shares of SHPH common stock.

Content

Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,095 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

Consists of 3,852 shares of SHPH common stock.